NGM Biopharmaceuticals Profit Margin 2018-2021 | NGM
Current and historical gross margin, operating margin and net profit margin for NGM Biopharmaceuticals (NGM) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. NGM Biopharmaceuticals net profit margin as of June 30, 2021 is -149.51%.
|NGM Biopharmaceuticals Annual Profit Margins
|NGM Biopharmaceuticals Quarterly Profit Margins
||Medical - Biomedical and Genetics
NGM Biopharmaceuticals Inc. is focused on developing novel therapeutics for underlying cardio-metabolic, liver, oncologic and ophthalmic diseases. The company's product pipeline consists of NGM282, NGM313, NGM120, NGM217, NGM621, NGM386 and NGM395 which are in clinical stage. NGM Biopharmaceuticals Inc. is based in San Francisco, California.